Related Experiment Video
Updated: Aug 8, 2026
Culture of myeloid dendritic cells from bone marrow precursors
Published on: July 26, 2008
Expansion of dendritic cells derived from human CD34+ cells in static and continuous perfusion cultures
D Soligo1, G Lambertenghi Deliliers, N Quirici
1Centro Trapianti di Midollo, Ospedale Maggiore IRCCS and University of Milan, Italy.
Insights
This study optimized dendritic cell (DC) expansion for immunotherapy. Continuous flow culture enhanced mature DC yield and function compared to static methods, showing promise for immunotherapeutic protocols.
Area of Science:
- Immunology
- Cell Biology
- Biotechnology
Background:
- Dendritic cells (DCs) are crucial for initiating immune responses.
- CD34+ progenitor cells are a source for generating DCs.
- Optimizing DC expansion is key for immunotherapeutic applications.
Purpose of the Study:
- To investigate cytokine combinations and culture conditions for expanding CD34+ derived DCs.
- To compare static versus continuous flow culture systems for DC generation.
- To evaluate the immunogenicity and characteristics of DCs produced under different conditions.
Main Methods:
- Expansion of CD34+ cells using serum-free conditions with specific cytokines (SCF, GM-CSF, TNF-alpha, TGF-beta, Flt-3 ligand).
- Culture of cells under static conditions versus continuous flow in an artificial capillary system.
- Analysis of cell surface antigen expression (HLA-DR, CD1a, S100, CD83, CD14, CD80), cell morphology (electron microscopy), and functional assays (mixed leucocyte reaction).
Main Results:
- Serum-free conditions with specific cytokines maximized DC expansion (102-fold increase in CD1a+ cells).
- Continuous flow culture yielded fewer total cells but a higher percentage of mature DCs (CD1a+/CD83+/CD80+) and reduced CD14+ cells compared to static culture.
- Flow-cultured DCs demonstrated enhanced stimulation of the mixed leucocyte reaction and exhibited characteristics of mature DCs with increased dendritic processes.
Conclusions:
- Continuous flow culture systems significantly improve the generation of mature, immunologically potent DCs from CD34+ precursors.
- The optimized method yields DCs particularly suitable for immunotherapeutic protocols.
- Further research into DC precursor populations in continuous perfusion cultures is warranted.
Abstract:
We examined the effects of different cytokine combinations and culture conditions on the expansion and modulation of cell surface antigens of CD34+ derived dendritic cells (DCs), the most efficient antigen-presenting cells capable of stimulating resting T cells in the primary immune response. Cells with a dendritic morphology and expressing HLA-DR, CD1a, S100 and CD83 were maximally expanded under serum-free conditions with the addition of SCF, GM-CSF, TNF-alpha, TGF-beta and Flt-3 ligand (fold increase of CD1a+ cells = 102 +/- 32 after 2 weeks of culture). CD34+ cells were also grown under continuous flow conditions in an artificial capillary system: after 14d of culture, the expansion in the total cell number was lower than that of the static cultures (3.3 +/- 2 v 18.9 +/- 4) but the percentage of CD1a+/CD83+/ CD80+ cells was considerably higher, whereas the CD14+ cells were significantly reduced (8.9 +/- 2 v 26 +/- 13). In continuous perfusion cultures, low levels of DC precursors and of LTC-IC were still present up to day 14. The DCs generated under flow conditions stimulated the mixed leucocyte reaction (MLR) more than the cells grown in static cultures. By electron microscopy, cells grown in the continuous flow system showed an increased number of large cells with numerous dendritic processes and abundant multilamellar complexes. The cells expanded under these conditions were sorted on the basis of their light-scatter properties into two fractions: one containing a predominance of CD1a+/S100+/ CD8 3+/CD80+/CD14- 'large cells' with great internal complexity (mature DCs); the second including 'small cells' either CD33+/CD14+, CD33+/CD15+ or CD33+/CD13-/CD14. The DCs generated and selected with this method are therefore particularly well suited for immunotherapeutic protocols.
